Nasopharyngeal Carcinoma: all 824 studies
Page 4 of 9. Open to participants first (281), then studies with results posted, then the rest; newest registration first within each.
- Acetylcysteine Rinse in Reducing Saliva Thickness and Mucositis in Patients With Head and Neck Cancer Undergoing Radiation TherapyCompletedNCT02123511Phase 2Results posted
- Phase Ib Study of BKM120 With Cisplatin and XRT in High Risk Locally Advanced Squamous Cell Cancer of Head and NeckCompletedNCT02113878Phase 1Results posted
- PI3K Inhibitor BKM120 and Cetuximab in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01816984Phase 1/2Results posted
- 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyCompletedNCT01806675Phase 1/2Results posted
- Selenomethionine in Reducing Mucositis in Patients With Locally Advanced Head and Neck Cancer Who Are Receiving Cisplatin and Radiation TherapyTerminatedNCT01682031Phase 2Results posted
- Effect of Bevacizumab on Radiation-induced Brain Necrosis in Patients With Nasopharyngeal CarcinomaCompletedNCT01621880Phase 2Results posted
- Low-level Laser Therapy to Prevent Oral Mucositis in Head and Neck PatientsCompletedNCT01439724Phase 3Results posted
- Akt Inhibitor MK2206 in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT01349933Phase 2Results posted
- Stereotactic Body Radiotherapy for Head and Neck TumorsCompletedNCT01344356Phase 4Results posted
- Erlotinib Hydrochloride and Radiation Therapy in Stage III-IV Squamous Cell Cancer of the Head and NeckTerminatedNCT01192815Phase 2Results posted
- Phase 2 Sequential and Concurrent Chemoradiation for Advanced Nasopharyngeal Carcinoma (NPC)CompletedNCT00896181Phase 2Results posted
- Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyTerminatedNCT00895245Phase 2Results posted
- A Phase II Study of Epstein-Barr Virus-Specific Immunotherapy for Nasopharyngeal CarcinomaCompletedNCT00834093Phase 2Results posted
- Functional Electrical Stimulation in Irradiated Nasopharyngeal Carcinoma (NPC)CompletedNCT00815087Phase 2Results posted
- Study of Cetuximab in Nasopharyngeal Carcinoma (NPC) With ChemoradiotherapyCompletedNCT00700440Phase 2Results posted
- To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal CancerCompletedNCT00697619Phase 2Results posted
- A Study of Gemcitabine and Cisplatin/Carboplatin Plus Erlotinib in Patients With Nasopharyngeal CancerCompletedNCT00603915Phase 2Results posted
- Proton Radiotherapy With Chemotherapy for Nasopharyngeal CarcinomaCompletedNCT00592501Phase 2Results posted
- Docetaxel in Combination With Cisplatin-5-fluorouracil for the Induction Treatment of Nasopharyngeal Carcinoma in Children and AdolescentsCompletedNCT00565448Phase 2Results posted
- Saracatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00513435Phase 2Results posted
- Dasatinib in Treating Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00507767Phase 2Results posted
- Bevacizumab in Reducing CNS Side Effects in Patients Who Have Undergone Radiation Therapy to the Brain for Primary Brain Tumor, Meningioma, or Head and Neck CancerCompletedNCT00492089Phase 2Results posted
- Pazopanib Hydrochloride in Treating Patients With Stage IV or Recurrent Nasopharyngeal CancerCompletedNCT00454142Phase 2Results posted
- Cisplatin and Radiation Therapy With or Without Erlotinib Hydrochloride in Treating Patients With Stage III or Stage IV Head and Neck CancerCompletedNCT00410826Phase 2Results posted
- Bevacizumab, Cisplatin, Radiation Therapy, and Fluorouracil in Treating Patients With Stage IIB, Stage III, Stage IVA, or Stage IVB Nasopharyngeal CancerCompletedNCT00408694Phase 2Results posted
- Sunitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck CancerCompletedNCT00387335Phase 2Results posted
- Study of High-Dose Chemotherapy With Bone Marrow or Stem Cell Transplant for Rare Poor-Prognosis CancersCompletedNCT00141765Phase 2Results posted
- Bortezomib With or Without Irinotecan in Treating Patients With Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and NeckCompletedNCT00103259Phase 2Results posted
- Radiation Therapy With or Without Chemotherapy in Reducing Mouth Dryness in Patients With Nasopharyngeal CancerCompletedNCT00057785Phase 2Results posted
- Biomarker Analysis Data From a Randomized Phase II Study in Patients With Nasopharyngeal Carcinoma Treated With Chemotherapy and RadiotherapyCompletedNCT07741110
- Tislelizumab Plus Chemotherapy With Response-Adapted Radiotherapy for de Novo Metastatic Nasopharyngeal Carcinoma: A Prospective, Phase II TrialActive, not recruitingNCT07248696Not applicable
- Concurrent Chemoradiotherapy With or Without Metronomic Capecitabine in High-Risk T1-2N1M0 NPCActive, not recruitingNCT07248670Phase 3
- Reduced-dose vs Standard-dose Irradiation for Low-risk Clinical Target Volume in Nasopharyngeal Carcinoma.Active, not recruitingNCT07201337Phase 3
- Upfront Neck Dissection Before Radiotherapy in Stage N3 Nasopharyngeal Carcinoma: A Retrospective StudyCompletedNCT07180173
- Validation of the 9th AJCC Staging System for NPC in Non-High-Incidence Areas in ChinaActive, not recruitingNCT07088861
- Brain Alterations Based on Multiplex MR Imaging in Nasopharyngeal Carcinoma Patients After Treatment, and Their Correlation With Clinical Cognitive Scores.Active, not recruitingNCT07011329
- Evaluation of Swallowing Muscles Using Ultrasonography and Shear Wave Elastography in Patients Receiving Radiotherapy for Nasopharyngeal Carcinoma DiagnosisCompletedNCT06934837
- Regulation of Blood-Brain Barrier Permeability by APOE Gene Polymorphism and Its Impact on Cognitive Function Post-Radiotherapy in Nasopharyngeal Carcinoma: an MRI StudyActive, not recruitingNCT06881225
- Tertiary Lymphoid Structures in Nasopharyngeal CarcinomaActive, not recruitingNCT06770699
- Comparison of Multi-omics Models for Early Nasopharyngeal Carcinoma Screening: cfDNA Methylation, EBV DNA, and Serological Double-antibodies DetectionActive, not recruitingNCT06763289
- Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal CarcinomaActive, not recruitingNCT06762470
- Toripalimab vs. Placebo Wtih GP Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT06712888Phase 3
- Compassionate Use of Asparaginase and Pembrolizumab Combination Theaapy for Nasopharyngeal CarcinomaCompletedNCT06676293Not applicable
- TPC Combined With Cadonilimab VS. TPC Alone in Anti-PD-1 Resistant Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT06664983Phase 3
- A Phase III Study of YL201 in Recurrent or Metastatic Nasopharyngeal Carcinoma (TAISHAN-301)Active, not recruitingNCT06629597Phase 3
- Long-term Outcomes of Early-stage Nasopharyngeal Carcinoma Patients Treated with Radiotherapy AloneActive, not recruitingNCT06612697
- Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition ManagementCompletedNCT06603909Not applicable
- Distribution of Bacteria in OME After Radiotherapy For NPC.Status unknownNCT06523933
- Combined Anti-IL6R and Anticoagulation Therapy in Advanced NPC PatientsActive, not recruitingNCT06442709Not applicable
- Nivolumab Plus Gemcitabine in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma-HN17-11CompletedNCT06440187Phase 2
- Irinotecan Liposomes in Combination With Nituzumab for the Treatment of Recurrent/Metastatic Nasopharyngeal Carcinoma After Failure of First-Line or Higher ImmunotherapyActive, not recruitingNCT06414577Phase 2
- Methylation-specific PCR Test for Early Screening and Early Diagnosis of Nasopharyngeal CarcinomaCompletedNCT06367049
- Massive Nasal Bleeding in Patients With NPC Received Curative RTCompletedNCT06348485
- Oral Enteral Nutrition in Delayed Onset Radiotherapy-related Swallowing Disorder in Nasopharyngeal CarcinomaCompletedNCT06301763Not applicable
- A Lithium-containing Mouthwash Prevention and Treatment of Oral Mucositis and Dysgeusia in Patients Undergoing RadiotherapyCompletedNCT06251050Phase 1/2
- Intermittent Oro-esophageal Tube Feeding in Late Dysphagia for Nasopharyngeal CarcinomaWithdrawnNCT06248879Not applicable
- Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal CarcinomaTerminatedNCT06248840Not applicable
- Retrospective Study on the Prediction of Radiation-induced Brain Injury in Patients With Nasopharyngeal CarcinomaCompletedNCT06244394
- Intermittent Oral-esophageal Tube Feeding in Delayed Dysphagia After Radiotherapy for Nasopharyngeal CarcinomaTerminatedNCT06189482Not applicable
- A Study Comparing BL-B01D1 With Physician's Choice of Chemotherapy in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma(PANKU-NPC01)Active, not recruitingNCT06118333Phase 3
- Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT06055816Phase 2
- Phase III Trial of Concurrent Chemotherapy Alone in Patients With Low-risk Nasopharyngeal CarcinomaActive, not recruitingNCT05979961Phase 3
- Testing Nivolumab and Ipilimumab Immunotherapy With or Without the Targeted Drug Cabozantinib in Recurrent, Metastatic, or Incurable Nasopharyngeal CancerSuspendedNCT05904080Phase 2
- Maintenance Therapy With Toripalimab Combined With Capecitabine/Placebo for Recurrent and Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT05869227Phase 3
- A Phase 1 Study of BRG01 in Subjects With Relapsed/Metastatic Epstein-Barr Virus (EBV)-Positive Nasopharyngeal CarcinomaCompletedNCT05864924Phase 1
- Patients with Stage III-IVa Nasopharyngeal Carcinoma with or Without a Mobile Medical Platform Full-course Nutritional InterventionCompletedNCT05834712Not applicable
- Neoadjuvant Chemotherapy Plus Toripalimab in Patients With Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT05813626Phase 2
- Reduced Volume of Neck Prophylactic Irradiation in Nasopharyngeal CarcinomaActive, not recruitingNCT05780372Phase 3
- Clincal Study of Reduced Target Radiotherapy in Nasopharyngeal CarcinomaCompletedNCT05741008Not applicable
- CDK4/6 Inhibitor Plus Camrelizumab for PD-1 Inhibitor Refractory R/M NPCStatus unknownNCT05724355Phase 2
- Trial of PRO1160 (GEN1160) in Relapsed or Refractory Non-Hodgkin Lymphoma (NHL) (PRO1160-001)TerminatedNCT05721222Phase 1/2
- A Bidirectional Study in Exploring the Dynamic Changes of Plasma and Urine Metabolites of Nasopharyngeal Carcinoma.Status unknownNCT05682703
- Development and Validation of a Deep Learning System for Nasopharyngeal Carcinoma Using Endoscopic ImagesStatus unknownNCT05627310
- Cadonilimab (PD-1/CTLA-4 Bispecific Blockade) and Chemoradiotherapy in Nasopharyngeal Carcinoma (GEMSTONE)Active, not recruitingNCT05587374Phase 3
- A Phase II/III Trial to Evaluate the Efficacy and Safety of QL1706 in Patients With Nasopharyngeal CarcinomaActive, not recruitingNCT05576272Phase 2/3
- Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal CancerCompletedNCT05564286Phase 3
- TQB2618 Injection Combined With Penpulimab Injection in the Treatment of Patients With Recurrent/Metastatic Nasopharyngeal CarcinomaCompletedNCT05563480Phase 2
- 89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsTerminatedNCT05563272Phase 2
- Development of Intelligent Model for Radioactive Brain Damage of Nasopharyngeal Carcinoma Based on Radio-metabolomicsStatus unknownNCT05547971
- A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersActive, not recruitingNCT05544929Phase 1
- Compression Therapy as a Prophylactic Method Against CIPN: a Prospective Self-controlled TrialActive, not recruitingNCT05531916Not applicable
- SBRT Combined With PD-1 Antibody and Chemotherapy in Oligometastatic Nasopharyngeal CarcinomaActive, not recruitingNCT05524168Phase 2
- PD-1 Inhibitors Plus Chemoradiotherapy for Metastatic Nasopharyngeal Carcinoma: an Open-label Single-arm, Phase II TrialActive, not recruitingNCT05520814Phase 2
- Phase II Clinical Study to Compare the Efficacy and Safety of HLX07 + Serplulimab +Chemotherapy Versus Placebo + Serplulimab + Chemotherapy in First-Line Treatment of Patients With Recurrent or Metastatic NPCActive, not recruitingNCT05513573Phase 2
- Low-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT05503914Not applicable
- A Prospective, Randomized, Controlled Clinical Study of BET Combined With Tympanostomy Tube Insertion in the Treatment of Intractable OME After Radiotherapy for NPCStatus unknownNCT05449184Not applicable
- Combining MRI and CEUS to Diagnose Small Cervical Lymph Node Metastases in NPC PatientsCompletedNCT05389306Not applicable
- PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal CarcinomaActive, not recruitingNCT05340270Phase 2
- Hearing Impairment of Nasopharyngeal CarcinomaCompletedNCT05330169
- Reduced-dose Versus Standard Dose Radiotherapy for Nasopharyngeal CarcinomainActive, not recruitingNCT05304468Phase 3
- BH4 in the Prevention and Treatment of Radiation-induced Skin Reactions for Head and Neck Squamous Cell Carcinoma (Including Nasopharyngeal Carcinoma)Status unknownNCT05299203Phase 1
- KL-A167 Injection Combined With Cisplatin and Gemcitabine vs Placebo Combined With Cisplatin and Gemcitabine in the Treatment of Recurrent or Metastatic Nasopharyngeal CarcinomaActive, not recruitingNCT05294172Phase 3
- Neoadjuvant Chemotherapy and Low-dose Radiotherapy Sequential Concurrent Chemoradiotherapy for Locally Advanced Nasopharyngeal CarcinomaCompletedNCT05292027Not applicable
- Radiotherapy Combined With PD-1 Monoclonal Antibody and Capecitabine in the Treatment of Nasopharyngeal CarcinomaWithdrawnNCT05290194Phase 2
- Study of Anlotinib With Chemoradiation for Patients With Locally Advanced Nasopharyngeal CarcinomaStatus unknownNCT05232552Phase 2
- Deep Learning Model for Diagnosis and Contour of Cervical Lymph Node for Nasopharyngeal CarcinomaStatus unknownNCT05231616
- PD-1 Combined With Intensity Modulated Radiation Therapy in the Treatment of Intermediate-risk Nasopharyngeal CarcinomaStatus unknownNCT05229315Phase 2
- A Randomized Controlled Clinical Trial of Surgery Versus Conservative Treatment for Mild and Moderate-grade Nasopharyngeal NecrosisStatus unknownNCT05228093Not applicable
- Neoadjuvant and Adjuvant Tislelizumab for Nasopharyngeal CarcinomaActive, not recruitingNCT05211232Phase 3
- Adjuvant Sintilimab Plus Capecitabine in Nasopharyngeal CarcinomaActive, not recruitingNCT05201859Phase 2